PETS — PetMed Express Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedSmall CapContrarian

Annual income statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K/A	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	284	309	272	257	281
Cost of Revenue
Gross Profit	81.2	89.9	76.9	70.7	78.6
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	253	272	248	251	289
Operating Profit	31	37.6	24.3	6.05	-8.16
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33.9	39.2	24.2	7.45	-6.27
Provision for Income Taxes
Net Income After Taxes	25.9	30.6	18.7	5.14	-7.46
Net Income Before Extraordinary Items
Net Income	25.9	30.6	18.7	5.14	-7.46
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25.9	30.6	18.7	5.14	-7.46
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.29	1.52	0.919	0.33	-0.296
Dividends per Share